Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias?
- PMID: 36610068
- PMCID: PMC10169440
- DOI: 10.1093/eurheartj/ehac638
Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias?
Conflict of interest statement
Conflict of interest: None declared.
Figures
Comment in
-
Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias? Reply.Eur Heart J. 2023 Feb 14;44(7):626. doi: 10.1093/eurheartj/ehac742. Eur Heart J. 2023. PMID: 36610071 Free PMC article. No abstract available.
Comment on
-
Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification.Eur Heart J. 2022 Oct 14;43(39):3960-3967. doi: 10.1093/eurheartj/ehac377. Eur Heart J. 2022. PMID: 35869873 Free PMC article.
References
-
- Mitchell RE, Hartley A, Walker VM, Gkatzionis A, Yarmolinsky J, Bell JA, et al. Strategies to investigate and mitigate collider bias in genetic and Mendelian randomization studies of disease progression. medRxiv, 10.1101/2022.04.22.22274166, 22 April 2022, preprint: not peer reviewed. - DOI - PMC - PubMed
